BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 26243660)

  • 1. A Broadly Cross-protective Vaccine Presenting the Neighboring Epitopes within the VP1 GH Loop and VP2 EF Loop of Enterovirus 71.
    Xu L; He D; Yang L; Li Z; Ye X; Yu H; Zhao H; Li S; Yuan L; Qian H; Que Y; Kuo Shih JW; Zhu H; Li Y; Cheng T; Xia N
    Sci Rep; 2015 Aug; 5():12973. PubMed ID: 26243660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B virus core particles containing multiple epitopes confer protection against enterovirus 71 and coxsackievirus A16 infection in mice.
    Huo C; Yang J; Lei L; Qiao L; Xin J; Pan Z
    Vaccine; 2017 Dec; 35(52):7322-7330. PubMed ID: 29129453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection against lethal enterovirus 71 challenge in mice by a recombinant vaccine candidate containing a broadly cross-neutralizing epitope within the VP2 EF loop.
    Xu L; He D; Li Z; Zheng J; Yang L; Yu M; Yu H; Chen Y; Que Y; Shih JW; Liu G; Zhang J; Zhao Q; Cheng T; Xia N
    Theranostics; 2014; 4(5):498-513. PubMed ID: 24669278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel combined vaccine based on monochimeric VLP co-displaying multiple conserved epitopes against enterovirus 71 and varicella-zoster virus.
    Wu Y; Zhu R; Xu L; Li Y; Li S; Yu H; Li S; Zhu H; Cheng T; Xia N
    Vaccine; 2017 May; 35(20):2728-2735. PubMed ID: 28408118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal Structures of Yeast-Produced Enterovirus 71 and Enterovirus 71/Coxsackievirus A16 Chimeric Virus-Like Particles Provide the Structural Basis for Novel Vaccine Design against Hand-Foot-and-Mouth Disease.
    Lyu K; He YL; Li HY; Chen R
    J Virol; 2015 Jun; 89(12):6196-208. PubMed ID: 25833050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel inactivated enterovirus 71 vaccine can elicit cross-protective immunity against coxsackievirus A16 in mice.
    Yang L; Liu Y; Li S; Zhao H; Lin Q; Yu H; Huang X; Zheng Q; Cheng T; Xia N
    Vaccine; 2016 Nov; 34(48):5938-5945. PubMed ID: 27771182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chimeric enterovirus 71 virus-like particle displaying conserved coxsackievirus A16 epitopes elicits potent immune responses and protects mice against lethal EV71 and CA16 infection.
    Luo J; Huo C; Qin H; Hu J; Lei L; Pan Z
    Vaccine; 2021 Jul; 39(30):4135-4143. PubMed ID: 34116877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hexon-modified recombinant E1-deleted adenoviral vectors as bivalent vaccine carriers for Coxsackievirus A16 and Enterovirus 71.
    Zhang C; Yang Y; Chi Y; Yin J; Yan L; Ku Z; Liu Q; Huang Z; Zhou D
    Vaccine; 2015 Sep; 33(39):5087-94. PubMed ID: 26296491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant virus-like particle presenting a newly identified coxsackievirus A10 neutralization epitope induces protective immunity in mice.
    Dai W; Xiong P; Zhang X; Liu Z; Chen J; Zhou Y; Ye X; Zhang C
    Antiviral Res; 2019 Apr; 164():139-146. PubMed ID: 30817941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of monovalent and bivalent vaccines against lethal Enterovirus 71 and Coxsackievirus A16 infection in newborn mice.
    Sun S; Jiang L; Liang Z; Mao Q; Su W; Zhang H; Li X; Jin J; Xu L; Zhao D; Fan P; An D; Yang P; Lu J; Lv X; Sun B; Xu F; Kong W; Jiang C
    Hum Vaccin Immunother; 2014; 10(10):2885-95. PubMed ID: 25483672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A combination vaccine comprising of inactivated enterovirus 71 and coxsackievirus A16 elicits balanced protective immunity against both viruses.
    Cai Y; Ku Z; Liu Q; Leng Q; Huang Z
    Vaccine; 2014 May; 32(21):2406-12. PubMed ID: 24657161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A virus-like particle-based tetravalent vaccine for hand, foot, and mouth disease elicits broad and balanced protective immunity.
    Zhang W; Dai W; Zhang C; Zhou Y; Xiong P; Wang S; Ye X; Liu Q; Zhou D; Huang Z
    Emerg Microbes Infect; 2018 May; 7(1):94. PubMed ID: 29777102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A virus-like particle based bivalent vaccine confers dual protection against enterovirus 71 and coxsackievirus A16 infections in mice.
    Ku Z; Liu Q; Ye X; Cai Y; Wang X; Shi J; Li D; Jin X; An W; Huang Z
    Vaccine; 2014 Jul; 32(34):4296-303. PubMed ID: 24950363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and characterization of a cross-neutralization epitope of Enterovirus 71.
    Liu CC; Chou AH; Lien SP; Lin HY; Liu SJ; Chang JY; Guo MS; Chow YH; Yang WS; Chang KH; Sia C; Chong P
    Vaccine; 2011 Jun; 29(26):4362-72. PubMed ID: 21501643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chimeric virus-like particle vaccines displaying conserved enterovirus 71 epitopes elicit protective neutralizing antibodies in mice through divergent mechanisms.
    Ye X; Ku Z; Liu Q; Wang X; Shi J; Zhang Y; Kong L; Cong Y; Huang Z
    J Virol; 2014 Jan; 88(1):72-81. PubMed ID: 24131712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and production of mouse scFv to specific epitope of enterovirus-71 virion protein-2 (VP2).
    Thanongsaksrikul J; Srimanote P; Tongtawe P; Glab-Ampai K; Malik AA; Supasorn O; Chiawwit P; Poovorawan Y; Chaicumpa W
    Arch Virol; 2018 May; 163(5):1141-1152. PubMed ID: 29356992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EV71 virus-like particles produced by co-expression of capsid proteins in yeast cells elicit humoral protective response against EV71 lethal challenge.
    Wang X; Xiao X; Zhao M; Liu W; Pang L; Sun X; Cen S; Yang BB; Huang Y; Sheng W; Zeng Y
    BMC Res Notes; 2016 Jan; 9():42. PubMed ID: 26809443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The compatibility of inactivated-Enterovirus 71 vaccination with Coxsackievirus A16 and Poliovirus immunizations in humans and animals.
    Mao Q; Wang Y; Shao J; Ying Z; Gao F; Yao X; Li C; Ye Q; Xu M; Li R; Zhu F; Liang Z
    Hum Vaccin Immunother; 2015; 11(11):2723-33. PubMed ID: 25715318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of conserved neutralizing linear epitopes within the VP1 protein of coxsackievirus A16.
    Shi J; Huang X; Liu Q; Huang Z
    Vaccine; 2013 Apr; 31(17):2130-6. PubMed ID: 23499595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cryo-electron microscopy study of insect cell-expressed enterovirus 71 and coxsackievirus a16 virus-like particles provides a structural basis for vaccine development.
    Gong M; Zhu H; Zhou J; Yang C; Feng J; Huang X; Ji G; Xu H; Zhu P
    J Virol; 2014 Jun; 88(11):6444-52. PubMed ID: 24672036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.